Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Brian P Mckeon. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Brian P Mckeon har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:ALKS / Alkermes plc | Director | 33 869 |
US:IDXX / IDEXX Laboratories, Inc. | EVP, CFO and Treasurer | 31 550 |
US:04685W103 / athenahealth, Inc. | Director | 0 |
US:IRM / Iron Mountain Incorporated | Chief Financial Officer | 10 991 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Brian P Mckeon. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp ALKS / Alkermes plc - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i ALKS / Alkermes plc. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2021-08-02 | ALKS | MCKEON BRIAN P | 10 000 | 26,4269 | 10 000 | 26,4269 | 264 269 | 57 | 32.13 | 57 031 | 21,58 |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel ALKS / Alkermes plc - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i ALKS / Alkermes plc. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til min |
Pris ved min |
Maks tap unngått ($) |
Maks tap unngått (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Brian P Mckeon som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-02 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −1 924 | 33 869 | −5,38 | 30,61 | −58 894 | 1 036 730 | |
2025-06-02 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 8 013 | 35 793 | 28,84 | ||||
2025-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −569 | 31 550 | −1,77 | 444,53 | −252 938 | 14 024 740 | |
2025-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 299 | 32 119 | 0,94 | ||||
2025-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 308 | 31 820 | 0,98 | ||||
2025-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 303 | 31 512 | 0,97 | ||||
2025-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 252 | 31 209 | 0,81 | ||||
2024-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −117 | 30 932 | −0,38 | 455,08 | −53 244 | 14 076 349 | |
2024-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 192 | 31 049 | 0,62 | ||||
2024-07-01 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −1 465 | 27 780 | −5,01 | 24,10 | −35 306 | 669 498 | |
2024-07-01 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 6 104 | 29 245 | 26,38 | ||||
2024-02-20 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 483 | 30 835 | 1,59 | 206,94 | 99 952 | 6 380 911 | |
2024-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −1 097 | 30 352 | −3,49 | 560,56 | −614 934 | 17 013 889 | |
2024-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 308 | 31 449 | 0,99 | ||||
2024-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 303 | 31 141 | 0,98 | ||||
2024-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 253 | 30 838 | 0,83 | ||||
2024-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 432 | 30 585 | 1,43 | ||||
2024-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 435 | 30 153 | 1,46 | ||||
2024-02-13 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −1 088 | 23 141 | −4,49 | 27,32 | −29 724 | 632 212 | |
2024-02-13 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 4 533 | 24 229 | 23,01 | ||||
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −681 | 29 718 | −2,24 | 572,80 | −390 080 | 17 022 359 | |
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −7 128 | 30 399 | −18,99 | 571,84 | −4 076 062 | 17 383 073 | |
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −5 675 | 37 527 | −13,14 | 570,97 | −3 240 253 | 21 426 547 | |
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −3 912 | 43 202 | −8,30 | 569,91 | −2 229 500 | 24 621 158 | |
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 469 | 47 114 | −3,02 | 568,84 | −835 633 | 26 800 327 | |
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 564 | 48 583 | −3,12 | 567,35 | −887 333 | 27 563 271 | |
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −701 | 50 147 | −1,38 | 566,53 | −397 140 | 28 409 700 | |
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 581 | 50 848 | −3,02 | 564,98 | −893 227 | 28 727 669 | |
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −615 | 52 429 | −1,16 | 563,82 | −346 747 | 29 560 069 | |
2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 23 326 | 53 044 | 78,49 | 141,60 | 3 302 962 | 7 510 973 | |
2023-08-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −117 | 29 692 | −0,39 | 504,08 | −58 977 | 14 967 318 | |
2023-08-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 192 | 29 809 | 0,65 | ||||
2023-07-10 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −1 430 | 19 696 | −6,77 | 29,88 | −42 728 | 588 516 | |
2023-07-10 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 5 957 | 21 126 | 39,27 | ||||
2023-05-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 560 | 29 605 | 1,93 | 178,26 | 99 826 | 5 277 449 | |
2023-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −1 208 | 29 031 | −3,99 | 503,65 | −608 409 | 14 621 283 | |
2023-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 303 | 30 239 | 1,01 | ||||
2023-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 253 | 29 936 | 0,85 | ||||
2023-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 433 | 29 683 | 1,48 | ||||
2023-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 435 | 29 250 | 1,51 | ||||
2023-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 504 | 28 815 | 1,78 | ||||
2023-02-10 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 4 445 | 15 169 | 41,45 | ||||
2022-08-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −90 | 28 276 | −0,32 | 407,78 | −36 700 | 11 530 242 | |
2022-08-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 192 | 28 366 | 0,68 | ||||
2022-06-16 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −795 | 10 724 | −6,90 | 27,19 | −21 616 | 291 586 | |
2022-06-16 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 7 585 | 11 519 | 192,81 | ||||
2022-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | −706 | 0 | −100,00 | ||||
2022-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 706 | 28 154 | 2,57 | 141,60 | 99 970 | 3 986 556 | |
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −253 | 4 785 | −5,02 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −433 | 5 038 | −7,91 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −435 | 5 471 | −7,37 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −505 | 5 906 | −7,88 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −459 | 6 411 | −6,68 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 1 212 | 6 870 | 21,42 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
A - Award | 197 | 197 | |||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 10 502 | 10 502 | |||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −964 | 27 448 | −3,39 | 505,53 | −487 331 | 13 875 607 | |
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 253 | 28 412 | 0,90 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 433 | 28 159 | 1,56 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 435 | 27 726 | 1,59 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 505 | 27 291 | 1,89 | ||||
2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 459 | 26 786 | 1,74 | ||||
2022-02-11 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −4 446 | 8 890 | −33,34 | ||||
2022-02-11 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −2 223 | 0 | −100,00 | ||||
2022-02-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −1 823 | 3 934 | −31,67 | 23,55 | −42 932 | 92 646 | |
2022-02-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 4 446 | 5 757 | 339,13 | ||||
2022-02-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −912 | 1 311 | −41,03 | 23,55 | −21 478 | 30 874 | |
2022-02-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 2 223 | 2 223 | |||||
2021-11-15 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −9 225 | 0 | −100,00 | ||||
2021-11-15 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 273 | 26 317 | −7,95 | 621,26 | −1 412 126 | 16 349 501 | |
2021-11-15 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −6 952 | 28 590 | −19,56 | 620,55 | −4 314 062 | 17 741 297 | |
2021-11-15 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 9 225 | 35 542 | 35,05 | 67,85 | 625 916 | 2 411 500 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −20 000 | 9 225 | −68,43 | ||||
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −872 | 26 317 | −3,21 | 629,80 | −549 186 | 16 574 232 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 375 | 27 189 | −4,81 | 628,78 | −864 574 | 17 095 707 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 974 | 28 564 | −9,43 | 627,97 | −1 867 572 | 17 937 008 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 813 | 31 538 | −5,44 | 626,74 | −1 136 282 | 19 765 937 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 326 | 33 351 | −6,52 | 625,46 | −1 454 831 | 20 859 650 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 142 | 35 677 | −5,66 | 624,53 | −1 337 747 | 22 281 198 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 493 | 37 819 | −3,80 | 623,34 | −930 649 | 23 573 933 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −5 743 | 39 312 | −12,75 | 622,36 | −3 574 235 | 24 466 139 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 262 | 45 055 | −2,72 | 621,40 | −784 203 | 27 996 820 | |
2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 20 000 | 46 317 | 76,00 | 67,85 | 1 357 000 | 3 142 584 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −6 310 | 29 225 | −17,76 | ||||
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −607 | 26 317 | −2,25 | 631,01 | −383 024 | 16 606 086 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −5 703 | 26 924 | −17,48 | 630,13 | −3 593 652 | 16 965 495 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 6 310 | 32 627 | 23,98 | 67,85 | 428 134 | 2 213 718 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −10 000 | 35 535 | −21,96 | ||||
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −110 | 26 317 | −0,42 | 632,19 | −69 541 | 16 637 176 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −743 | 26 427 | −2,73 | 631,39 | −469 122 | 16 685 478 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −971 | 27 170 | −3,45 | 630,39 | −612 112 | 17 127 572 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 094 | 28 141 | −6,93 | 629,63 | −1 318 446 | 17 718 207 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 356 | 30 235 | −7,23 | 628,19 | −1 480 024 | 18 993 206 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 326 | 32 591 | −3,91 | 627,41 | −831 942 | 20 447 594 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 100 | 33 917 | −3,14 | 626,47 | −689 122 | 21 247 918 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 300 | 35 017 | −3,58 | 625,25 | −812 824 | 21 894 131 | |
2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 10 000 | 36 317 | 38,00 | 67,85 | 678 500 | 2 464 084 | |
2021-08-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −192 | 5 658 | −3,28 | ||||
2021-08-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −96 | 26 308 | −0,36 | 705,76 | −67 753 | 18 566 882 | |
2021-08-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 192 | 26 404 | 0,73 | ||||
2021-08-04 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
P - Purchase | 10 000 | 10 000 | 26,43 | 264 269 | 264 269 | ||
2021-06-16 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
A - Award | 7 585 | 7 585 | |||||
2021-06-16 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
A - Award | 15 677 | 15 677 | |||||
2021-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | −1 474 | 0 | −100,00 | ||||
2021-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 474 | 26 188 | 5,96 | 67,85 | 100 011 | 1 776 856 | |
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 307 | 24 714 | −5,02 | 539,58 | −705 231 | 13 335 180 | |
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −433 | 5 850 | −6,89 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −435 | 6 283 | −6,48 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −505 | 6 718 | −6,99 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −459 | 7 223 | −5,98 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −810 | 7 682 | −9,54 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 1 011 | 8 492 | 13,51 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
A - Award | 183 | 183 | |||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 9 538 | 9 538 | |||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −1 335 | 26 021 | −4,88 | 544,08 | −726 347 | 14 157 506 | |
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 433 | 27 356 | 1,61 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 435 | 26 923 | 1,64 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 505 | 26 488 | 1,94 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 459 | 25 983 | 1,80 | ||||
2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 810 | 25 524 | 3,28 | ||||
2021-02-11 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
A - Award | 2 223 | 2 223 | |||||
2021-02-11 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
A - Award | 4 549 | 4 549 | |||||
2021-02-11 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
A - Award | 13 336 | 13 336 | |||||
2021-02-11 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
A - Award | 26 169 | 26 169 | |||||
2020-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −3 000 | 18 050 | −14,25 | 478,13 | −1 434 380 | 8 630 189 | |
2020-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 100 | 21 050 | −9,07 | 476,89 | −1 001 466 | 10 038 503 | |
2020-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −300 | 23 150 | −1,28 | 475,50 | −142 650 | 11 007 825 | |
2020-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −3 338 | 23 450 | −12,46 | 475,02 | −1 585 625 | 11 139 278 | |
2020-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 241 | 26 788 | −4,43 | 474,14 | −588 404 | 12 701 177 | |
2020-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −21 | 28 029 | −0,07 | 472,88 | −9 931 | 13 254 418 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −36 216 | 0 | −100,00 | ||||
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −200 | 24 700 | −0,80 | 481,26 | −96 252 | 11 887 122 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −566 | 24 900 | −2,22 | 480,31 | −271 854 | 11 959 639 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 534 | 25 466 | −5,68 | 479,69 | −735 851 | 12 215 900 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −390 | 27 000 | −1,42 | 477,02 | −186 036 | 12 879 446 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −3 596 | 27 390 | −11,61 | 476,01 | −1 711 740 | 13 037 974 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −3 474 | 30 986 | −10,08 | 475,20 | −1 650 846 | 14 724 560 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −244 | 34 460 | −0,70 | 473,97 | −115 648 | 16 332 934 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 407 | 34 704 | −6,49 | 473,04 | −1 138 602 | 16 416 300 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 107 | 37 111 | −2,90 | 472,20 | −522 721 | 17 523 666 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 493 | 38 218 | −6,12 | 471,02 | −1 174 259 | 18 001 534 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 850 | 40 711 | −6,54 | 469,80 | −1 338 921 | 19 125 898 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −9 617 | 43 561 | −18,08 | 469,09 | −4 511 281 | 20 434 221 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −6 338 | 53 178 | −10,65 | 467,97 | −2 965 970 | 24 885 507 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 400 | 59 516 | −2,30 | 467,01 | −653 820 | 27 794 817 | |
2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 36 216 | 60 916 | 146,62 | 79,54 | 2 880 621 | 4 845 259 | |
2020-08-20 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | −1 256 | 0 | −100,00 | ||||
2020-08-20 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | −1 880 | 0 | −100,00 | ||||
2020-08-20 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 256 | 52 732 | 2,44 | 79,54 | 99 902 | 4 194 303 | |
2020-08-20 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 880 | 51 486 | 3,79 | 53,18 | 99 988 | 2 738 283 | |
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −37 098 | 0 | −100,00 | ||||
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −37 836 | 0 | −100,00 | ||||
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −8 790 | 0 | −100,00 | ||||
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −3 049 | 49 596 | −5,79 | 381,48 | −1 163 118 | 18 919 654 | |
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −14 469 | 52 645 | −21,56 | 380,12 | −5 499 962 | 20 011 438 | |
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −37 209 | 67 114 | −35,67 | 379,20 | −14 109 701 | 25 449 716 | |
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −28 997 | 104 323 | −21,75 | 377,84 | −10 956 290 | 39 417 632 | |
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 37 098 | 133 320 | 38,55 | 62,00 | 2 300 076 | 8 265 840 | |
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 37 836 | 96 222 | 64,80 | 53,18 | 2 012 308 | 5 117 567 | |
2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 8 790 | 58 386 | 17,72 | 43,68 | 383 947 | 2 550 300 | |
2020-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −193 | 7 481 | −2,51 | ||||
2020-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −97 | 49 596 | −0,20 | 395,71 | −38 384 | 19 625 633 | |
2020-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 193 | 49 693 | 0,39 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −435 | 7 674 | −5,36 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −505 | 8 109 | −5,86 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −459 | 8 614 | −5,06 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −810 | 9 073 | −8,20 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −628 | 9 883 | −5,97 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 1 731 | 10 511 | 19,72 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 17 813 | 17 813 | |||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −979 | 49 457 | −1,94 | 288,78 | −282 716 | 14 282 192 | |
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 435 | 50 436 | 0,87 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 505 | 50 001 | 1,02 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 459 | 49 496 | 0,94 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 810 | 49 037 | 1,68 | ||||
2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 628 | 48 227 | 1,32 | ||||
2019-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 961 | 8 780 | 12,29 | ||||
2019-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 10 058 | 0 | −100,00 | ||||
2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −7 504 | 0 | −100,00 | ||||
2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −629 | 47 528 | −1,31 | 248,79 | −156 492 | 11 824 695 |
2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −5 771 | 48 157 | −10,70 | 248,28 | −1 432 819 | 11 956 377 |
2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −225 | 53 928 | −0,42 | 247,28 | −55 638 | 13 335 375 |
2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −375 | 54 153 | −0,69 | 245,77 | −92 165 | 13 309 324 |
2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −300 | 54 528 | −0,55 | 244,57 | −73 372 | 13 336 093 |
2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −204 | 54 828 | −0,37 | 242,72 | −49 514 | 13 307 611 |
2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 7 504 | 55 032 | 15,79 | 44,04 | 330 514 | 2 423 884 | |
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −505 | 7 819 | −6,07 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −459 | 8 324 | −5,23 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −811 | 8 783 | −8,45 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −629 | 9 594 | −6,15 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −726 | 10 223 | −6,63 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | 2 175 | 10 949 | 24,79 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | 483 | 483 | |||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | 20 753 | 20 753 | |||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −1 612 | 47 496 | −3,28 | 206,94 | −333 587 | 9 828 822 | |
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 505 | 49 108 | 1,04 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 459 | 48 603 | 0,95 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 811 | 48 144 | 1,71 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 629 | 47 333 | 1,35 | ||||
2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 726 | 46 704 | 1,58 | ||||
2019-02-13 |
|
4 | ATHN |
ATHENAHEALTH INC
Common Stock |
D - Sale to Issuer | −2 721 | 0 | −100,00 | 135,00 | −367 335 | ||
2019-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −2 820 | 8 774 | −24,32 | ||||
2019-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −1 006 | 45 978 | −2,14 | 186,02 | −187 136 | 8 552 828 | |
2019-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 2 820 | 48 984 | 6,11 | ||||
2018-06-08 |
|
4 | ATHN |
ATHENAHEALTH INC
Common Stock |
A - Award | 1 931 | 2 721 | 244,43 | ||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −459 | 11 594 | −3,81 | ||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −811 | 12 053 | −6,30 | ||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −629 | 12 864 | −4,66 | ||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −726 | 13 493 | −5,11 | ||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 2 524 | 14 219 | 21,58 | ||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
A - Award | 560 | 560 | |||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 25 140 | 25 140 | |||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −903 | 44 040 | −2,01 | 178,26 | −160 969 | 7 850 570 | |
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 459 | 44 943 | 1,03 | ||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 811 | 44 484 | 1,86 | ||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 629 | 43 673 | 1,46 | ||||
2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 726 | 43 044 | 1,72 | ||||
2018-02-13 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | −1 880 | 1 880 | −50,00 | ||||
2018-02-13 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 880 | 42 318 | 4,65 | 53,18 | 99 988 | 2 250 683 | |
2018-02-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −6 602 | 0 | −100,00 | ||||
2018-02-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −1 200 | 40 438 | −2,88 | 182,33 | −218 792 | 7 372 923 |
2018-02-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −3 706 | 41 638 | −8,17 | 181,44 | −672 406 | 7 554 678 |
2018-02-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −1 696 | 45 344 | −3,61 | 180,53 | −306 171 | 8 185 735 |
2018-02-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 6 602 | 47 040 | 16,33 | 38,80 | 256 125 | 1 824 917 | |
2018-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −2 820 | 11 695 | −19,43 | ||||
2018-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −1 095 | 40 438 | −2,64 | 156,38 | −171 236 | 6 323 694 | |
2018-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 2 820 | 41 533 | 7,28 | ||||
2017-09-06 |
|
4 | ATHN |
ATHENAHEALTH INC
Common Stock |
A - Award | 790 | 790 | |||||
2017-02-21 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | −1 880 | 3 760 | −33,33 | ||||
2017-02-21 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 880 | 38 548 | 5,13 | 53,18 | 99 988 | 2 050 175 | |
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −811 | 14 515 | −5,29 | ||||
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −629 | 15 326 | −3,94 | ||||
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −726 | 15 955 | −4,35 | ||||
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 2 295 | 16 681 | 15,95 | ||||
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
A - Award | 706 | 706 | |||||
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 23 326 | 23 326 | |||||
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −809 | 36 668 | −2,16 | 141,60 | −114 554 | 5 192 189 | |
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 811 | 37 477 | 2,21 | ||||
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 629 | 36 666 | 1,75 | ||||
2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 726 | 36 037 | 2,06 | ||||
2017-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
M - Exercise | −9 924 | 0 | −100,00 | ||||
2017-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −970 | 35 311 | −2,67 | 142,24 | −137 971 | 5 022 573 |
2017-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −8 954 | 36 281 | −19,79 | 141,57 | −1 267 620 | 5 136 308 |
2017-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 9 924 | 45 235 | 28,10 | 26,66 | 264 524 | 1 205 739 | |
2017-01-04 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −2 820 | 14 386 | −16,39 | ||||
2017-01-04 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −1 105 | 35 311 | −3,03 | 117,27 | −129 583 | 4 140 921 | |
2017-01-04 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 2 820 | 36 416 | 8,39 | ||||
2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −629 | 17 206 | −3,53 | ||||
2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −726 | 17 835 | −3,91 | ||||
2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 4 053 | 18 561 | 27,94 | ||||
2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
A - Award | 1 474 | 1 474 | |||||
2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 45 535 | 45 535 | |||||
2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −505 | 33 331 | −1,49 | 67,85 | −34 264 | 2 261 508 | |
2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 629 | 33 816 | 1,90 | ||||
2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 726 | 33 187 | 2,24 | ||||
2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −629 | 17 206 | −3,53 | ||||
2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −726 | 17 835 | −3,91 | ||||
2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 4 053 | 18 561 | 27,94 | ||||
2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
A - Award | 1 474 | 1 474 | |||||
2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 35 535 | 45 535 | 355,35 | ||||
2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −505 | 33 331 | −1,49 | 67,85 | −34 264 | 2 261 508 | |
2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 629 | 33 816 | 1,90 | ||||
2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 726 | 33 187 | 2,24 | ||||
2016-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −9 054 | 0 | −100,00 | ||||
2016-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −4 854 | 32 461 | −13,01 | 70,06 | −340 080 | 2 274 279 |
2016-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −4 200 | 37 315 | −10,12 | 69,17 | −290 507 | 2 581 015 |
2016-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 9 054 | 41 515 | 27,89 | 17,18 | 155 593 | 713 435 | |
2016-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | −1 880 | 5 640 | −25,00 | ||||
2016-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 880 | 32 461 | 6,15 | 53,18 | 99 988 | 1 726 438 | |
2016-01-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −2 820 | 14 508 | −16,27 | ||||
2016-01-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −1 129 | 30 581 | −3,56 | 72,92 | −82 327 | 2 229 967 | |
2016-01-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 2 820 | 31 710 | 9,76 | ||||
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −3 000 | 14 445 | −17,20 | 157,36 | −472 088 | 2 273 104 |
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −2 000 | 17 445 | −10,29 | 156,44 | −312 873 | 2 729 036 |
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 5 000 | 19 445 | 34,61 | 29,27 | 146 350 | 569 155 | |
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −363 | 8 664 | −4,02 | ||||
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 1 572 | 9 027 | 21,09 | ||||
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right to buy) |
A - Award | 628 | 628 | |||||
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
A - Award | 18 108 | 18 108 | |||||
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −117 | 14 445 | −0,80 | 159,08 | −18 612 | 2 297 911 | |
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 363 | 14 562 | 2,56 | ||||
2015-02-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right to buy) |
M - Exercise | −940 | 3 760 | −20,00 | ||||
2015-02-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 940 | 14 199 | 7,09 | 106,37 | 99 988 | 1 510 348 | |
2015-01-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −1 411 | 7 455 | −15,91 | ||||
2015-01-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −493 | 13 259 | −3,58 | 148,27 | −73 097 | 1 965 912 | |
2015-01-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 411 | 13 752 | 11,43 | ||||
2014-10-31 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 934 | 0 | −100,00 | ||||
2014-10-31 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −2 934 | 12 341 | −19,21 | 142,17 | −417 127 | 1 754 520 |
2014-10-31 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 2 934 | 15 275 | 23,77 | 56,95 | 167 091 | 869 911 | |
2014-05-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 800 | 0 | −100,00 | ||||
2014-05-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −4 800 | 12 341 | −28,00 | 126,05 | −605 040 | 1 555 583 |
2014-05-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 4 800 | 17 141 | 38,89 | 30,50 | 146 376 | 522 715 | |
2014-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 1 815 | 8 866 | 25,74 | ||||
2014-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
A - Award | 18 549 | 18 549 | |||||
2014-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 7 051 | 7 051 | |||||
2014-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right to buy) |
A - Award | 4 700 | 4 700 | |||||
2014-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
A - Award | 18 918 | 18 918 | |||||
2013-06-07 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock, par value $.01 per share |
P - Purchase | 3 600 | 10 991 | 48,71 | 28,61 | 103 010 | 314 495 | |
2013-05-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Options (right to buy) |
A - Award | 4 395 | 4 395 | |||||
2013-05-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Deferred Stock Unit |
A - Award | 429 | 7 513 | 6,06 | ||||
2013-03-19 |
|
4 | IRM |
IRON MOUNTAIN INC
Restricted Stock Units |
A - Award | 13 793 | 13 793 | |||||
2013-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Performance Units |
A - Award | 17 021 | 17 021 | |||||
2013-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Restricted Stock Units |
D - Sale to Issuer | −6 340 | 12 700 | −33,30 | ||||
2013-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Restricted Stock Units |
D - Sale to Issuer | −2 343 | 2 351 | −49,91 | ||||
2013-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock, par value $.01 per share |
F - Taxes | −2 809 | 7 391 | −27,54 | 35,31 | −99 186 | 260 976 | |
2013-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock, par value $.01 per share |
A - Award | 8 683 | 10 200 | 572,38 | ||||
2012-11-26 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock, par value $.01 per share |
A - Award | 123 | 1 517 | 8,82 | ||||
2012-11-13 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 666 | 0 | −100,00 | ||||
2012-11-13 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −6 666 | 12 341 | −35,07 | 90,48 | −603 152 | 1 116 636 | |
2012-11-13 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 6 666 | 19 007 | 54,02 | 17,12 | 114 089 | 325 305 | |
2012-10-22 |
|
4 | IRM |
IRON MOUNTAIN INC
Employee Stock Option (Right to Buy) |
A - Award | 5 942 | 55 440 | 12,00 | ||||
2012-10-22 |
|
4 | IRM |
IRON MOUNTAIN INC
Employee Stock Option (Right to Buy) |
A - Award | 9 547 | 89 072 | 12,01 | ||||
2012-10-22 |
|
4 | IRM |
IRON MOUNTAIN INC
Employee Stock Option (Right to Buy) |
A - Award | 6 942 | 64 774 | 12,00 | ||||
2012-05-11 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
A - Award | 3 752 | 3 752 | |||||
2012-05-11 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Deferred Stock Unit |
A - Award | 369 | 7 084 | 5,50 | ||||
2012-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Restricted Stock Units |
D - Sale to Issuer | 2 132 | 4 272 | 99,63 | ||||
2012-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock, par value $.01 per share |
F - Taxes | −738 | 1 394 | −34,62 | 28,74 | −21 210 | 40 064 | |
2012-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock, par value $.01 per share |
A - Award | 2 132 | 2 132 | |||||
2012-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Restricted Stock Units |
A - Award | 17 328 | 17 328 | |||||
2012-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Performance Units |
A - Award | 14 177 | 14 177 | |||||
2012-03-13 |
|
4/A | IRM |
IRON MOUNTAIN INC
Restricted Stock Units |
A - Award | 6 404 | 6 404 | |||||
2011-03-15 |
|
4 | IRM |
IRON MOUNTAIN INC
Employee Stock Option (Right to Buy) |
A - Award | 49 498 | 49 498 | |||||
2011-03-15 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock |
A - Award | 6 404 | 6 404 |